Broadridge Financial Solutions Total Cost of Revenue increased by 7.0% to $1.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $1.24B to $1.33B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 7.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $914.10M | $978.40M | $1.08B | $1.15B | $990.40M | $988.20M | $1.14B | $1.16B | $1.08B | $1.06B | $1.19B | $1.25B | $1.08B | $1.15B | $1.24B | $1.30B | $1.17B | $1.24B | $1.33B |
| QoQ Change | — | -10.1% | +7.0% | +10.1% | +6.4% | -13.6% | -0.2% | +15.1% | +1.9% | -7.2% | -1.7% | +12.3% | +5.5% | -14.2% | +6.6% | +7.9% | +4.8% | -9.9% | +6.3% | +7.0% |
| YoY Change | — | — | — | — | +12.8% | +8.3% | +1.0% | +5.6% | +1.1% | +8.6% | +7.0% | +4.4% | +8.1% | -0.0% | +8.4% | +4.1% | +3.4% | +8.5% | +8.2% | +7.3% |